Drug Profile
DTaP vaccine adult - GSK
Alternative Names: 776423; Boostrix; dTpa Booster Vaccine (263855); Refortrix; Tetanus toxoid reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix) - GSKLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Pertussis; Tetanus
Most Recent Events
- 10 Oct 2022 Launched for Diphtheria in Ukraine, Iceland, Liechtenstein, Norway, Turkey, Indonesia, Canada, Philippines, Chile and China (IM)
- 10 Oct 2022 Launched for Pertussis in Chile, Philippines, Canada, Indonesia, Turkey, Liechtenstein, Iceland, Ukraine, Norway and China (IM)
- 10 Oct 2022 Launched for Tetanus in Ukraine, Iceland, Liechtenstein, Norway, Turkey, Indonesia, Canada, Philippines, Chile and China (IM)